More than 1,000 people in the UK contract bacterial meningitis every year, with tragically nearly one in five cases proving fatal. Health experts warn that this preventable disease disproportionately affects teenagers and young adults, who may be more likely to experience severe symptoms due to their age.
Meningitis is a highly infectious condition caused by inflammation of the membranes surrounding the brain and spinal cord. If left untreated, it can lead to life-threatening complications such as septicaemia (blood poisoning), permanent brain damage, hearing loss, and limb loss. According to NHS England data, in 2020-21, there were over 1,100 cases of meningitis reported in the UK, with more than a third of these cases occurring among teenagers and young adults aged 15-24.
Currently, the Meningitis ACWY vaccine is offered as part of the routine NHS vaccination schedule to all 13 to 15-year-olds (school year 9 or 10) in England. However, experts recommend extending this programme to cover all teenagers, regardless of previous vaccination history or specific strain focus. This approach aims to fill immunity gaps and further reduce meningitis cases.
The teenage years are a critical period for meningitis transmission due to increased social interaction and the close living conditions found in colleges and university accommodation. Experts believe that widespread vaccination among teenagers would not only protect individuals but also contribute to herd immunity, safeguarding the wider community.
Implementing such a programme would require significant logistical planning and investment from the NHS, including ensuring adequate vaccine supply, training healthcare professionals, and launching public awareness campaigns to encourage uptake. While these costs may seem high upfront, experts predict that the long-term benefits in terms of lives saved and reduced debilitating health complications will far outweigh them.